The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Prostate cancer in young men: an important clinical entity
Open accessAbstract
Prostate cancer is considered a disease of older men (aged >65 years), but today over 10% of new diagnoses in the USA occur in young men aged ≤55 years. Early-onset prostate cancer, that is prostate cancer diagnosed at age ≤55 years, differs from prostate cancer diagnosed at an older age in several ways. Firstly, among men with high-grade and advanced-stage prostate cancer, those diagnosed at a young age have a higher cause-specific mortality than men diagnosed at an older age, except those over age 80 years. This finding suggests that important biological differences exist between early-onset prostate cancer and late-onset disease. Secondly, early-onset prostate cancer has a strong genetic component, which indicates that young men with prostate cancer could benefit from evaluation of genetic risk. Furthermore, although the majority of men with early-onset prostate cancer are diagnosed with low-risk disease, the extended life expectancy of these patients exposes them to long-term effects of treatment-related morbidities and to long-term risk of disease progression leading to death from prostate cancer. For these reasons, patients with early-onset prostate cancer pose unique challenges, as well as opportunities, for both research and clinical communities. Current data suggest that early-onset prostate cancer is a distinct phenotype—from both an aetiological and clinical perspective—that deserves further attention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Finding the missing heritability of complex diseases
Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., et al. (2009) · Nature · doi:10.1038/nature08494 · Cited by 8,336
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Brocken, P., van der Heijden, H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus-Oei, L.-F. (2014) · Respiration · doi:10.1159/000347096 · Cited by 4,002
Beighton, P., & Beighton, G. (1997) · The Person Behind the Syndrome · doi:10.1007/978-1-4471-0925-9_118 · Cited by 3,159
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Wilt, T. J., Brawer, M. K., Jones, K. M., Barry, M. J., Aronson, W. J., Fox, S., Gingrich, J. R., Wei, J. T., Gilhooly, P., Grob, B. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113162 · Cited by 1,770
Evolution and functional impact of rare coding variation from deep sequencing of human exomes
Tennessen, J. A., Bigham, A. W., O’Connor, T. D., Fu, W., Kenny, E. E., Gravel, S., McGee, S., Do, R., Liu, X., Jun, G., et al. (2012) · Science · doi:10.1126/science.1219240 · Cited by 1,613
National Center for Health Statistics ( NCHS )
Feinleib, M. (2005) · Encyclopedia of Biostatistics · doi:10.1002/0470011815.b2a16042 · Cited by 1,574
Uncovering the roles of rare variants in common disease through whole-genome sequencing
Cirulli, E. T., & Goldstein, D. B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2779 · Cited by 1,136
Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
Cooperberg, M. R., Broering, J. M., & Carroll, P. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.0133 · Cited by 1,006
Genetic susceptibility to non-polyposis colorectal cancer
Lynch, H. T., & de la Chapelle, A. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.11.801 · Cited by 814
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
Self-citationMendelian inheritance of familial prostate cancer.
Carter, B. S., Beaty, T. H., Steinberg, G. D., Childs, B., & Walsh, P. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3367 · Cited by 781
Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Ewing, C. M., Ray, A. M., Lange, E. M., Zuhlke, K. A., Robbins, C. M., Tembe, W. D., Wiley, K. E., Isaacs, S. D., Johng, D., Wang, Y., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110000 · Cited by 658
Self-citationAn abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people
Nelson, M. R., Wegmann, D., Ehm, M. G., Kessner, D., St. Jean, P., Verzilli, C., Shen, J., Tang, Z., Bacanu, S.-A., Fraser, D., et al. (2012) · Science · doi:10.1126/science.1217876 · Cited by 647
Cumulative Association of Five Genetic Variants with Prostate Cancer
Zheng, S. L., Sun, J., Wiklund, F., Smith, S., Stattin, P., Li, G., Adami, H.-O., Hsu, F.-C., Zhu, Y., Bälter, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075819 · Cited by 631
Recent Explosive Human Population Growth Has Resulted in an Excess of Rare Genetic Variants
Keinan, A., & Clark, A. G. (2012) · Science · doi:10.1126/science.1217283 · Cited by 548
On the theory of screening for chronic diseases
ZELEN, M., & FEINLEIB, M. (1969) · Biometrika · doi:10.1093/biomet/56.3.601 · Cited by 416
Lynch, B. M. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0815 · Cited by 372
Prostate cancer epidemiology in the United States
Brawley, O. W. (2012) · World Journal of Urology · doi:10.1007/s00345-012-0824-2 · Cited by 333
de MOURA, A. (1962) · PubMed · Cited by 288
Meta-Analysis of Measures of Sexual Activity and Prostate Cancer
Dennis, L. K., & Dawson, D. V. (2002) · Epidemiology · doi:10.1097/00001648-200201000-00012 · Cited by 274
Droz, J., Balducci, L., Bolla, M., Emberton, M., Fitzpatrick, J. M., Joniau, S., Kattan, M. W., Monfardini, S., Moul, J. W., Naeim, A., et al. (2010) · BJU International · doi:10.1111/j.1464-410x.2010.09334.x · Cited by 258
Zeliadt, S. B., Ramsey, S. D., Penson, D. F., Hall, I. J., Ekwueme, D. U., Stroud, L., & Lee, J. W. (2006) · Cancer · doi:10.1002/cncr.21822 · Cited by 251
Zeegers, M. P. A., Jellema, A., & Ostrer, H. (2003) · Cancer · doi:10.1002/cncr.11262 · Cited by 223
International Consortium for Prostate Cancer Genetics, Xu, J., Lange, E. M., Lu, L., Zheng, S. L., Wang, Z., Thibodeau, S. N., Cannon-Albright, L. A., Teerlink, C. C., Camp, N. J., et al. (2013) · Human Genetics · doi:10.1007/s00439-012-1229-4 · Cited by 201
Self-citationGudmundsson, J., Sulem, P., Gudbjartsson, D. F., Masson, G., Agnarsson, B. A., Benediktsdottir, K. R., Sigurdsson, A., Magnusson, O. T., Gudjonsson, S. A., Magnusdottir, D. N., et al. (2012) · Nature Genetics · doi:10.1038/ng.2437 · Cited by 183
An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis
Kiciński, M., Vangronsveld, J., & Nawrot, T. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027130 · Cited by 181
Lin, D. W., Porter, M., & Montgomery, B. (2009) · Cancer · doi:10.1002/cncr.24324 · Cited by 174
Treatment decisions for localized prostate cancer: Asking men what’s important
Holmboe, E. S., & Concato, J. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.90842.x · Cited by 159
Meat and dairy consumption and subsequent risk of prostate cancer in a US cohort study
Rohrmann, S., Platz, E. A., Kavanaugh, C. J., Thuita, L. W., Hoffman, S. C., & Helzlsouer, K. J. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0082-y · Cited by 140
Aly, M., Wiklund, F., Xu, J., Isaacs, W. B., Eklund, M., D’Amato, M., Adolfsson, J., & Grönberg, H. (2011) · European Urology · doi:10.1016/j.eururo.2011.01.017 · Cited by 130
Zeggini, E., Rayner, W., Morris, A. P., Hattersley, A. T., Walker, M., Hitman, G. A., Deloukas, P., Cardon, L. R., & McCarthy, M. I. (2005) · Nature Genetics · doi:10.1038/ng1670 · Cited by 112
Is there age bias in the treatment of localized prostate carcinoma?
Alibhai, S. M. H., Krahn, M. D., Cohen, M. M., Fleshner, N. E., TOMLINSON, G. A., & Naglie, G. (2003) · Cancer · doi:10.1002/cncr.11884 · Cited by 107
Treatment decision‐making for localized prostate cancer: What younger men choose and why
Sidana, A., Hernandez, D. J., Feng, Z., Partin, A. W., Trock, B. J., Saha, S., & Epstein, J. I. (2011) · The Prostate · doi:10.1002/pros.21406 · Cited by 103
Beuten, J., Gelfond, J., Franke, J. L., Weldon, K. S., Crandall, A. C., Johnson‐Pais, T. L., Thompson, I. M., & Leach, R. J. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0076 · Cited by 100
Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer
Breyer, J. P., Avritt, T. G., McReynolds, K. M., Dupont, W. D., & Smith, J. R. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0495 · Cited by 90
Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era
Chen, Y., Page, J. H., Chen, R., & Giovannucci, E. L. (2008) · The Prostate · doi:10.1002/pros.20825 · Cited by 89
Lin, D. W., FitzGerald, L. M., Fu, R., Kwon, E. M., Zheng, S. L., Kolb, S., Wiklund, F. E., Stattin, P. E., Isaacs, W. B., Xu, J., et al. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0236 · Cited by 89
Estimation of absolute risk for prostate cancer using genetic markers and family history
Xu, J., Sun, J., Kader, A. K., Lindström, S., Wiklund, F. E., Hsu, F., Johansson, J., Zheng, S. L., Thomas, G. D., Hayes, R. B., et al. (2009) · The Prostate · doi:10.1002/pros.21002 · Cited by 83
Laitinen, V. H., Wahlfors, T., Saaristo, L., Rantapero, T., Pelttari, L. M., Kilpivaara, O., Laasanen, S., Kallioniemi, A. H., Nevanlinna, H. A., Aaltonen, L. A., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1000-t · Cited by 83
Kim, Y.-R., Oh, K. J., Park, R., Xuân, N. T., Kang, T.-W., Kwon, D., Choi, C., Kim, M. S., Kim, K. K., Ahn, K. Y., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-124 · Cited by 83
Early onset prostate cancer has a significant genetic component
Lange, E. M., Salinas, C. A., Zuhlke, K. A., Ray, A. M., Wang, Y., Lu, Y., Ho, L. A., Luo, J., & Cooney, K. A. (2011) · The Prostate · doi:10.1002/pros.21414 · Cited by 82
Self-citationClinical utility of five genetic variants for predicting prostate cancer risk and mortality
Salinas, C. A., Koopmeiners, J. S., Kwon, E. M., FitzGerald, L. M., Lin, D. W., Ostrander, E. A., Feng, Z., & Stanford, J. L. (2008) · The Prostate · doi:10.1002/pros.20887 · Cited by 80
Self-citationA population model of prostate cancer incidence
Tsodikov, A., Szabó, A., & Wegelin, J. (2006) · Statistics in Medicine · doi:10.1002/sim.2257 · Cited by 58
Self-citationKlein, R. J., Halldén, C., Gupta, A., Savage, C. J., Dahlin, A., Bjartell, A. S., Manjer, J., Scardino, P. T., Ulmert, D., Wallström, P., et al. (2011) · European Urology · doi:10.1016/j.eururo.2011.10.047 · Cited by 57
Lindström, S., Schumacher, F. R., Cox, D. G., Travis, R. C., Albanes, D., Allen, N. E., Andriole, G. L., Berndt, S. I., Boeing, H., Bueno-de-Mesquita, H. B., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1038 · Cited by 57
Outcomes for men younger than 50 years undergoing radical prostatectomy
Twiss, C. O., Slova, D., & Lepor, H. (2005) · Urology · doi:10.1016/j.urology.2005.01.049 · Cited by 55
Utility of Incorporating Genetic Variants for the Early Detection of Prostate Cancer
Nam, R. K., Zhang, W., Trachtenberg, J., Seth, A. K., Klotz, L. H., Stanimirovic, A., Punnen, S., Venkateswaran, V., Toi, A., Loblaw, D. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1593 · Cited by 53
Burri, R. J., Ho, A. Y., Forsythe, K., Cesaretti, J. A., Stone, N. N., & Stock, R. G. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.052 · Cited by 52
Evaluation of 8q24 and 17q Risk Loci and Prostate Cancer Mortality
Penney, K. L., Salinas, C. A., Pomerantz, M. M., Schumacher, F. R., Beckwith, C. A., Lee, G. M., Oh, W. K., Sartor, O. A., Ostrander, E. A., Kurth, T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2733 · Cited by 52
Self-citationCumulative effect of five genetic variants on prostate cancer risk in multiple study populations
Sun, J., Chang, B., Isaacs, S. D., Wiley, K. E., Wiklund, F. E., Stattin, P. E., Duggan, D. J., Carpten, J. D., Trock, B. J., Partin, A. W., et al. (2008) · The Prostate · doi:10.1002/pros.20793 · Cited by 51
HOXB13 mutations in a population‐based, case–control study of prostate cancer
Stott‐Miller, M., Karyadi, D. M., Smith, T., Kwon, E. M., Kolb, S., Stanford, J. L., & Ostrander, E. A. (2012) · The Prostate · doi:10.1002/pros.22604 · Cited by 50
HOXB13 Mutation and Prostate Cancer: Studies of Siblings and Aggressive Disease
Witte, J. S., Mefford, J., Plummer, S. J., Liu, J., Cheng, I. C., Klein, E. A., Rybicki, B. A., & Casey, G. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1154 · Cited by 48
Sun, J., Kader, A. K., Hsu, F., Kim, S., Zhu, Y., Turner, A. R., Jin, T., Zhang, Z., Adolfsson, J., Wiklund, F. E., et al. (2010) · The Prostate · doi:10.1002/pros.21256 · Cited by 47
Established Prostate Cancer Susceptibility Variants are not Associated with Disease Outcome
Wiklund, F. E., Adami, H., Zheng, S. L., Stattin, P. E., Isaacs, W. B., Grönberg, H., & Xu, J. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1148 · Cited by 46
Genetic Variants and Family History Predict Prostate Cancer Similar to Prostate-Specific Antigen
Zheng, S. L., Sun, J., Wiklund, F. E., Gao, Z., Stattin, P. E., Purcell, L. D., Adami, H., Hsu, F., Zhu, Y., Adolfsson, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1743 · Cited by 40
Chromosome 8q24 risk variants in hereditary and non‐hereditary prostate cancer patients
Sun, J., Lange, E. M., Isaacs, S. D., Liu, W., Wiley, K. E., Lange, L. A., Grönberg, H., Duggan, D. J., Carpten, J. D., Walsh, P. C., et al. (2008) · The Prostate · doi:10.1002/pros.20695 · Cited by 39
Helfand, B. T., Fought, A. J., Loeb, S., Meeks, J. J., Kan, D., & Catàlona, W. J. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.04.032 · Cited by 31
Helfand, B. T., Kan, D., Modi, P. K., & Catàlona, W. J. (2010) · The Prostate · doi:10.1002/pros.21253 · Cited by 17
Cited by
The Epidemiology of Prostate Cancer
Pernar, C. H., Ebot, E. M., Wilson, K. M., & Mucci, L. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030361 · Cited by 773
Zhou, C. K., Check, D. P., Lortet‐Tieulent, J., Laversanne, M., Jemal, A., Ferlay, J., Bray, F., Cook, M. B., & Devesa, S. S. (2016) · International Journal of Cancer · doi:10.1002/ijc.29894 · Cited by 322
Giri, V. N., Knudsen, K. E., Kelly, W. K., Cheng, H. H., Cooney, K. A., Cookson, M. S., Dahut, W., Weissman, S., Soule, H. R., Petrylak, D. P., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00046 · Cited by 275
Self-citationTrama, A., Botta, L., Foschi, R., Ferrari, A., Stiller, C., Desandes, E., Maule, M. M., Merletti, F., & Gatta, G. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00162-5 · Cited by 265
Metadata
- Authors
- Salinas, C. A., Tsodikov, A., Ishak-Howard, M., & Cooney, K. A.
- Venue
- Nature Reviews Urology
- Published
- 2014-05-13
- Volume
- 11
- Issue
- 6
- Pages
- 317-323
- ISSN
- 1759-4812 (ISSN-L)
- 1759-4820
- OpenAlex
- W1972266686
- Cited by
- 304
- References
- 63
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.